Reginald Seeto files SEC Form 4 disclosures for CareDx, Inc.. They have made 18 open-market trades across 2 companies since 2017, most recently 2023-10-02.
CIK 0001688485
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 18 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CDNA | SELL · 10b5-1 | 2023-10-02 | 2023-10-02 | $6.91 | $19K | -21.8% | -20.7% | +75.1% |
| CDNA | SELL · 10b5-1 | 2023-09-05 | 2023-09-05 | $9.49 | $27K | -13.6% | -25.3% | +7.6% |
| CDNA | SELL · 10b5-1 | 2023-08-14 | 2023-08-14 | $8.89 | $5K | -11.1% | -14.3% | -19.2% |
| CDNA | SELL · 10b5-1 | 2023-08-02 | 2023-08-02 | $11.35 | $32K | -16.2% | -12.7% | -51.5% |
| CDNA | SELL | 2023-07-13 | 2023-07-13 | $10.33 | $109K | +8.6% | -7.8% | -42.0% |
| CDNA | SELL · 10b5-1 | 2023-07-03 | 2023-07-03 | $8.48 | $24K | +16.3% | +34.0% | -18.3% |
| CDNA | SELL | 2023-06-28 | 2023-06-28 | $8.76 | $250K | +18.7% | +28.1% | -15.5% |
| CDNA | SELL · 10b5-1 | 2023-06-02 | 2023-06-02 | $8.13 | $23K | -3.1% | +5.3% | +15.5% |
| CDNA | SELL · 10b5-1 | 2023-05-02 | 2023-05-04 | $8.12 | $23K | -11.5% | -9.1% | +28.2% |
| CDNA | SELL · 10b5-1 | 2023-04-03 | 2023-04-03 | $8.95 | $25K | +1.3% | -2.9% | -3.2% |
| CDNA | SELL · 10b5-1 | 2023-03-02 | 2023-03-06 | $15.88 | $45K | +1.4% | -9.9% | -16.2% |
| CDNA | SELL | 2023-02-09 | 2023-02-13 | $15.85 | $621K | -3.1% | -33.7% | -44.1% |
| CDNA | SELL | 2023-02-07 | 2023-02-08 | $16.40 | $101K | -16.0% | -40.5% | -46.8% |
| CDNA | SELL · 10b5-1 | 2023-02-02 | 2023-02-03 | $17.15 | $48K | -4.7% | -35.3% | -47.7% |
| CDNA | SELL · 10b5-1 | 2023-01-03 | 2023-01-03 | $11.69 | $33K | +27.5% | +57.7% | -21.8% |
| CDNA | SELL | 2022-03-21 | 2022-03-23 | $40.43 | $234K | +1.9% | -21.6% | -47.0% |
| CDNA | SELL | 2022-03-01 | 2022-03-01 | $38.62 | $244K | -19.3% | -3.0% | -34.0% |
| CDNA | SELL | 2022-02-09 | 2022-02-10 | $45.00 | $115K | -19.4% | -36.0% | -50.8% |
| CDNA | SELL | 2022-02-02 | 2022-02-04 | $40.69 | $665K | +5.5% | -20.1% | -21.3% |
| CDNA | SELL · 10b5-1 | 2022-02-01 | 2022-02-03 | $42.13 | $34K | +7.7% | -20.8% | -16.0% |
| CDNA | SELL | 2022-01-18 | 2022-01-19 | $40.06 | $389K | +9.5% | -0.1% | -11.7% |
| CDNA | SELL | 2021-08-27 | 2021-08-27 | $80.00 | $53K | -13.5% | -23.0% | -47.3% |
| CDNA | SELL | 2021-07-08 | 2021-07-09 | $85.55 | $906K | -3.8% | -8.6% | -24.6% |
| CDNA | SELL | 2021-06-25 | 2021-08-17 | $95.50 | $4.3M | +13.9% | -3.9% | -33.0% |
| CDNA | SELL | 2021-06-24 | 2021-06-25 | $95.31 | $2.0M | -9.8% | -14.1% | -30.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.